Preview

Pharmacy & Pharmacology

Advanced search

DEVELOPMENT OF THE METHODS OF STANDARTIZATION DRY EXTRACT AND MEDICAL DRUGS GINKGO BILOBA

https://doi.org/10.19163/2307-9266-2017-5-3-222-241

Abstract

The article presents new approaches to standardization of dry extract and medicinal preparations (MD) of ginkgo bilobate. Methods for the spectrophotometric determination of flavonoids, terpenolactones and ginkgoic acids in the active pharmaceutical substance “Ginkgo biloba dry extract “ (further in the text “ginkgo extract”), as well as methods for analysis of MD “GINKGO, tablets coated with 40 mg” (“GINKGO”, Tablets) and “GINKGO, solution for enteral use, 40 mg/ml “(“GINKGO, solution”). The aim – development and validation of methods for standardization of plant-derived APS – ginkgo extract, as well as MD based on it. Materials and methods. The samples of the APS “Ginkgo biloba dry extract “, MD “GINKGO, tablets” and “GINKGO, solution”, produced by CJSC “VIFITEH” (Russia) served as the objects of the study. Research methods: spectrophotometry (further in the text “SF-metry”) and high-performance liquid chromatography (HPLC). Used equipment: SF-56 spectrophotometer manufactured by LLC “LOMO-SPECTR” (Russia) and liquid chromatograph of the brand Shimadzu Prominence LC-20AD (Japan) with software control and computer processing of analysis results. Results and discussion. The use of the method of SF-metry optimizes the analysis process not only during the standardization of the finished product, but also at all stages of industrial production of MD within the framework of interoperational control. The content of the sum of flavonoids in the samples of two series of ginkgo extract in terms of rutine was determined by direct SF-metry – (29.64 ± 0.36)% and (28.88 ± 0.54)%; method of differential SF-metry – (21.78 ± 0.41) and (20.98 ± 0.24)%. The content of the amount of flavonoids in the preparations “GINKGO, tablets” and “GINKGO, solution” was: by direct SF-metry – (9.84 ± 0.15) mg/tab. and (10.07 ± 0.10) mg/ml; Method of differential SF-metry – (7.33 ± 1.13) mg/tab. and (8.30 ± 0.13) mg/ml, respectively. The analogues “MEMOPLANT” (“Dr. Willimar Schwabe GmbH & Co. KG”) and “TANAKAN®” (“Beaufour Ipsen Industrie”) were analyzed – the results obtained are comparable. Methods for quantitative determination of the amount of terpenolactones in the APS by the method of differential SF-metry and the residual content of the sum of ginkgoic acids by the direct SF-metry method are developed. During their approbation it was found that the amount of ginkgolactones in the samples studied is 7.87 ± 0.17% and 8.03 ± 0.22%, calculated as bilobalide, and the residual content of ginkgoic acid does not exceed 10 ppm. The expediency and effectiveness of using the HPLC method for simultaneous determination of the authenticity and evaluation of the benign nature of the substance and MD ginkgo was confirmed. Conclusion. The methods of the SF metric quantification of the amount of funds have been developed. The developed methods meet the validation tests, are characterized by accuracy and reproducibility in combination with simplicity of execution and are tested in the conditions of pharmaceutical production.

About the Authors

M. A. Marchenko
CJSC «VIFITEH»
Russian Federation
chemical engineer


I. N. Zilfikarov
CJSC «VIFITEH», All-Russian Science Research Institute of Medicinal and Aromatic Plants
Russian Federation
Doctor of Sciences (Pharmacy), Professor


T. A. Ibragimov
Dagestan State University, Dagestan State Medical University
Russian Federation
Candidate of Sciences (Pharmacy), Associate Professor of the Department
of Analytical Chemistry and Pharmaceutical


A. G. Maleev
CJSC «VIFITEH»
Russian Federation
engineer hromatografist


References

1. Gosudarstvennyj reestr lekarstvennyh sredstv RF [State register of medicines of the Russian Federation]. URL: grls.rosminzdrav.ru (access data 04.04.2017) (In Russ.)

2. Tan M.S., Yu J.T., Tan C.C., Wanq H.F., Menq X.F., Wanq C., Jiang T., Zhu X.C., Tan L. EFFICACY AND ADVERSE EFFECTS OF GINKGO BILOBA FOR COGNITIVE IMPAIRMENT AND DEMENTIA: A SYSTEMATIC REVIEW AND META-ANALYSIS. J. Alzheimers Dis. 2015. V. 43(2). P. 589-603. DOI: 10.3233/ JAD-140837

3. Onbysh T.E., Makarova L.M., Pogorely V.E. MEKHANIZMY REALIZACII FARMAKOLOGICHESKOJ AKTIVNOSTI EKSTRAKTA GINKGO BILOBA [MECHANISMS FOR THE REALIZATION OF THE PHARMACOLOGICAL ACTIVITY OF THE GINKGO BILOBA EXTRACT]. Sovremennye naukoemkie tekhnologii [Modern science-intensive technologies]. 2005. No 5. P. 22-25. URL: https://www.top-technologies.ru/ru/article/view?id=22912 (access data: 04.04.2017). (In Russ.)

4. Korchagin D.V., Kurkina A.V., Dubishchev A.V., Kochneva ON, Gusev D.O. IZUCHENIE NEJROTROPNOJ AKTIVNOSTI LEKARSTVENNYH PREPARATOV NA OSNOVE LISTEV GINKGO DVULOPASTNOGO [STUDY OF NEUROTROPIC ACTIVITY OF DRUGS BASED ON GINKGO LEAVES OF BILOBATE]. Fundamentalnye issledovaniya [Fundamental research]. 2013. No. 10-4. P. 812-815. URL: https://www.fundamental- research.ru/ru/article/view?id=32407 (access data: 04.04.2017). (In Russ.)

5. Kovrov G.V., Palatov S.Y., Lebedev M.A., Machulina A.I. INSOMNIYA I KOGNITIVNYE NARUSHENIYA [INSOMNIA AND COGNITIVE IMPAIRMENT]. Effektivnaya farmakoterapiya [Effective pharmacotherapy]. 2014. No 31. P. 28-33. (In Russ.)

6. Kurkin V.A., Petrukhin I.K. AKTUALNYE ASPEKTY SOZDANIYA IMPORTOZAMESHCHAYUSHCHIH LEKARSTVENNYH RASTITELNYH PREPARATOV [ACTUAL ASPECTS OF THE CREATION OF IMPORT-SUBSTITUTING HERBAL MEDICINES]. Fundamentalnye issledovaniya [Fundamental research].2014. No. 11. P. 366-371. URL: https://www.fundamental-research.ru/ru/article/view?id=35529 ( access data:04.04.2017) (In Russ.)

7. Eller K.I, Balusova A.S, Komarova E.L. OCENKA PODLINNOSTI RASTITELNYH EKSTRAKTOV KAK SYRYA DLYA BAD GINKGO BILOBA GINKGO BILOBA [EVALUATION OF AUTHENTICITY OF VEGETABLE EXTRACTS, AS RAW MATERIALS FOR BAD. GINKGO BILOBA – GINKGO BILOBA]. Rynok BAD [Market BAD]. 2005. No. 4. P.29-30. (In Russ.)

8. Gosudarstvennaya Farmakopeya Rossijskoj Federacii v 3 t XIII izd [State Pharmacopoeia of the Russian Federation: 3 vol. XIII ed]. Moskva [Moscow], 2015. URL: http://www.femb.ru/feml (access data: 14.03.2017). (In Russ.)

9. Sasakia K., Wada K., Haga M. CHEMISTRY AND BIOLOGICAL ACTIVITIES OF GINKGO BILOBA // Studies in Natural Products Chemistry. Vol. 28. Part I. 2003. P. 165-198. DOI: 10.1016/S1572-5995(03)80141-2

10. Shklyaev S.A., Pidpruzhnikov Y.V. VERIFIKACIYA METODIKI KILKISNOGO VIZNACHENNYA GINKGOFLAVONOGL KOZIDIV V LIKARSKOMU ZASOBI SHCHO MISTIT EKSTRAKT GINKGO BILOBA [VERIFICATION OF THE METHOD FOR THE QUANTITATIVE DETERMINATION OF GINKGO-FLAVONOGLYCOSIDIV IN A DRUG CONTAINING THE EXTRACT OF GINKGO BILOBA]. Upravlinnya ekonomika ta zabezpechennyayakosti [Management, Economics and Provision of Liquidity]. 2012. No. 3. P. 4-8 (In Ukr.)

11. Sloley B.D., Tawfik S.R., Scherban K.A., Tam Y.K. QUALITY CONTROL ANALYSES FOR GINKGO EXTRACTS REQUIRE ANALYSIS OF INTACT FLAVONOL GLYCOSIDES. J. Food Drug Anal. 2003. Vol.11. No. 2. P. 102–107.

12. Daironas Zh.V., Korochinsky A.V., Zilfikarov I.N. MICROSCOPY OF THE DIAGNOSTIC ELEMENTS OF THE LEAVES OF GINKGO BILOBATE AND GRASS OF THE MEADOWSWEED IN THE TABLETS “GINKGOTROPIL”. Pharmacy & Pharmacology. 2016. Vol. 4. No. 1. P. 36-45.

13. Kurkina A.V., Kalabukhova E.A., Vlasova G.I., Demidova G.A., Avdeev E.V. OBOSNOVANIE NOVYH PODHODOV K STANDARTIZACII LISTEV GINKGO DVULOPASTNOGO S POMOSHCHYU METODA VEZHKH [SUBSTANTIATION OF NEW APPROACHES TO THE STANDARDIZATION OF GINKGO BILOBATE LEAVES USING THE HPLC METHOD]. Sovremennye problemy nauki i obrazovaniya [Modern problems of science and education]. 2013. No. 4. P. 352. (In Russ.)

14. Beek T.A. CHEMICAL ANALYSIS OF GINKGO BILOBA LEAVES AND EXTRACTS. Journal of Chromatography. 2002. Vol. 967. Is.1. P. 21-55. DOI: 10.1016/S0021-9673(02)00172-3

15. Ginkgo biloba (Ginkgo biloba L.). Analiticheskij obzor [Ginkgo biloba (Ginkgo biloba L.) (Analytical review)]. URL: http: // www.npkfarm.ru/dlya-spetsialistov/ginkgo-biloba-ginkgo-biloba-l-analiticheskiy-obzor.html (access data: 15/05/2017). (In Russ.)

16. . Kurkina A.V, Zagoskina N.V., Ryanskova T.K. SOSTAV I SODERZHANIE FLAVONOIDOV V LISTYAH GINKGO BILOBA GINKGOACEAE KULTIVIRUEMOGO V RAZLICHNYH REGIONAH ROSSII [COMPOSITION AND CONTENT OF FLAVONOIDS IN THE LEAVES OF GINKGO BILOBA (GINKGOACEAE), CULTIVATED IN VARIOUS REGIONS OF RUSSIA]. Rastitelnye resursy [Vegetable resources]. 2013. Vol. 49. No. 3. P. 410-415. (In Russ.)

17. Fuzzati N., Pace R., Villa F. A SIMPLE HPLC-UV METHOD FOR THE ASSAY OF GINKGOLIC ACIDS IN GINKGO BILOBA EXTRACTS. Fitoterapia. 2003. №74. P.247–256. DOI: 10.1016/S0367-326X(03)00040-6

18. United States Pharmacopeia. 31-th Ed. Rockville: United States Pharmacopoeial Convention. Inc., 2008.

19. Kurkin V.A., Bulankin D.G., Daeva E.D., Kadentsev V.I. FLAVONOIDY LISTEV GINKGO DVULOPASTNOGO GINKGO BILOBA L [FLAVONOIDS FROM THE LEAVES OF GINKGO BILOBA (GINKGO BILOBA L.)]. Himiya rastitelnogo syrya [Chemistry of plant raw materials]. 2012. No. 2. P. 85-88. (In Russ.)

20. European Pharmacopoeia 7.0 04/2008: 1827. P. 1531-1534

21. Orlova S.E, Zilfikarov I.N, Aliev A.M. SRAVNITELNOE FITOHIMICHESKOE ISSLEDOVANIE SPIRTOVOGO I UGLEKISLOTNOGO EKSTRAKTOV PALMY SABALYA [COMPARATIVE PHYTOCHEMICAL STUDY OF ALCOHOL AND CARBON DIOXIDE EXTRACTS OF THE PALM OF THE CABAL]. Himiya rastitelnogo syrya [Chemistry of plant raw materials]. 2012. No. 4. P. 137-142. (In Russ.)


Review

For citations:


Marchenko M.A., Zilfikarov I.N., Ibragimov T.A., Maleev A.G. DEVELOPMENT OF THE METHODS OF STANDARTIZATION DRY EXTRACT AND MEDICAL DRUGS GINKGO BILOBA. Pharmacy & Pharmacology. 2017;5(3):222-241. (In Russ.) https://doi.org/10.19163/2307-9266-2017-5-3-222-241

Views: 1837


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2307-9266 (Print)
ISSN 2413-2241 (Online)